Holen Sie sich die Stockscreener-App
2.93
0.69%
0.02
Handel nachbörslich:
2.88
-0.05
-1.71%
Schlusskurs vom Vortag:
$2.91
Offen:
$2.96
24-Stunden-Volumen:
46,706
Relative Volume:
0.58
Marktkapitalisierung:
$43.84M
Einnahmen:
$37.79M
Nettoeinkommen (Verlust:
$-10.38M
KGV:
-4.0137
EPS:
-0.73
Netto-Cashflow:
$-1.00M
1W Leistung:
-8.72%
1M Leistung:
-2.33%
6M Leistung:
-36.85%
1J Leistung:
+112.32%
1-Tages-Spanne:
$2.85
$3.00
1-Wochen-Bereich:
$2.63
$3.4884
52-Wochen-Spanne:
$1.04
$7.25
Cumberland Pharmaceuticals Inc Stock (CPIX) Company Profile
Firmenname
Cumberland Pharmaceuticals Inc
Sektor
Telefon
615-255-0068
Adresse
2525 WEST END AVENUE, NASHVILLE,, TN
Vergleichen Sie CPIX mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
CPIX
Cumberland Pharmaceuticals Inc
|
2.93 | 42.49M | 37.79M | -10.38M | -1.00M | -0.73 |
|
ZTS
Zoetis Inc
|
152.44 | 66.04B | 9.39B | 2.61B | 2.22B | 5.81 |
|
TAK
Takeda Pharmaceutical Co Adr
|
14.77 | 45.57B | 29.98B | 958.27M | 5.31B | 0.2964 |
|
HLN
Haleon Plc Adr
|
9.69 | 42.50B | 14.35B | 1.85B | 0 | 0.4023 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
17.21 | 18.84B | 16.54B | -1.64B | 749.00M | -1.45 |
|
UTHR
United Therapeutics Corp
|
309.72 | 13.59B | 2.99B | 1.21B | 1.13B | 25.06 |
Cumberland Pharmaceuticals Inc Stock (CPIX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2012-11-12 | Bestätigt | UBS | Neutral |
| 2011-02-01 | Bestätigt | UBS | Neutral |
| 2010-12-16 | Herabstufung | UBS | Buy → Neutral |
| 2010-08-17 | Herabstufung | Jefferies | Buy → Hold |
| 2010-08-17 | Bestätigt | Morgan Joseph | Buy |
| 2010-08-17 | Bestätigt | UBS | Buy |
| 2010-05-14 | Bestätigt | Morgan Joseph | Buy |
Alle ansehen
Cumberland Pharmaceuticals Inc Aktie (CPIX) Neueste Nachrichten
Detecting price anomalies in Cumberland Pharmaceuticals Inc. with AIPortfolio Update Summary & Free Fast Gain Swing Trade Alerts - Newser
Cumberland Pharmaceuticals Inc. stock volume spike explainedMarket Volume Report & Real-Time Chart Breakout Alerts - Newser
Will Cumberland Pharmaceuticals Inc. bounce back from current support2025 Technical Overview & Weekly Watchlist for Hot Stocks - Newser
What indicators show strength in Cumberland Pharmaceuticals Inc.2025 Sector Review & Community Shared Stock Ideas - Newser
Institutional scanner results for Cumberland Pharmaceuticals Inc.Earnings Risk Report & Detailed Earnings Play Alerts - Newser
Using data tools to time your Cumberland Pharmaceuticals Inc. exitTrade Performance Summary & Consistent Income Trade Ideas - Newser
Can Cumberland Pharmaceuticals Inc. ride the EV waveTriple Profit Stock Tactics - newsyoung.net
Real time social sentiment graph for Cumberland Pharmaceuticals Inc.Investment Timeline and ROI Summary Report - Newser
When is the best time to exit Cumberland Pharmaceuticals Inc.High Probability Trade Outcome Prediction - Newser
How to build a custom watchlist for Cumberland Pharmaceuticals Inc.ROI Focused Watchlist with Trade Confidence - Newser
Cumberland outlines continued momentum with 23% revenue growth and advances ifetroban clinical program - MSN
What data driven models say about Cumberland Pharmaceuticals Inc.’s futureReal Time Trade Execution Alert Plan - Newser
Will Cumberland Pharmaceuticals Inc. continue its uptrendFree Conservative Entry for High Return Setup - Newser
Will Cumberland Pharmaceuticals Inc. outperform the marketAI Pattern Recognition and Trade Prediction - Newser
How Cumberland Pharmaceuticals Inc. stock performs during market volatilityFree Weekly Setup With 3x Return Potential - Newser
Tools to monitor Cumberland Pharmaceuticals Inc. recovery probabilityFree Entry Alert Based on Volume Spikes - Newser
Sector ETF performance correlation with Cumberland Pharmaceuticals Inc.Free Secure Capital Picks With Upside Potential - Newser
Short interest data insights for Cumberland Pharmaceuticals Inc.Free Reliable Investment Entry Point Signals - Newser
Top chart patterns to watch in Cumberland Pharmaceuticals Inc.Summary of Trade Cycles in 5-Year Range - Newser
Applying sector rotation models to Cumberland Pharmaceuticals Inc.Reliable Setup Screener with Low Risk - Newser
Published on: 2025-08-10 21:21:24 - Newser
Real time breakdown of Cumberland Pharmaceuticals Inc. stock performanceSmart Stock Forecast Using AI Algorithms - Newser
Using economic indicators to assess Cumberland Pharmaceuticals Inc. potentialSmart Entry Signals for Active Traders - Newser
Cumberland Pharmaceuticals Inc. Stock Performance After Earnings: Historical InsightsMomentum-Based Prediction for Quick Returns - Newser
Understanding Cumberland Pharmaceuticals Inc.’s price movementDaily Technical Forecast for Quick Gains - Newser
Cumberland Pharmaceuticals Advances IPF Treatment with Ifetroban Study - The Globe and Mail
Cumberland Pharmaceuticals (NASDAQ:CPIX) Downgraded to “Buy” Rating by Wall Street Zen - Defense World
CUMBERLAND PHARMACEUTICALS INC SEC 10-Q Report - TradingView
Cumberland Pharmaceuticals Inc. (NASDAQ:CPIX) Q2 2025 Earnings Call Transcript - Insider Monkey
Cumberland Pharmaceuticals’ Earnings Call Highlights Growth and Expansion - TipRanks
Key External Factors That Drive Cumberland Pharmaceuticals Inc. Stock Price MovementsFree Weekly Hot Picks With Buy Confidence - Newser
Cumberland (CPIX) Q2 Revenue Up 10% - AOL.com
Cumberland Pharmaceuticals Q2 Financial Results OverviewNews and Statistics - IndexBox
Cumberland: Q2 Earnings Snapshot - Huron Daily Tribune
Cumberland Pharmaceuticals Inc (CPIX) Q2 2025 Earnings Call Highlights: Revenue Growth and ... By GuruFocus - Investing.com Canada
Cumberland Pharmaceuticals Q2 2025: Unpacking Key Contradictions in Production, Margins, and Growth Outlook - AInvest
Cumberland Pharmaceuticals Reports Strong Revenue Growth - TipRanks
Earnings call transcript: Cumberland Pharmaceuticals Q2 2025 sees revenue growth amid stock dip By Investing.com - Investing.com South Africa
Earnings call transcript: Cumberland Pharmaceuticals Q2 2025 sees revenue growth amid stock dip - Investing.com Canada
Cumberland Pharmaceuticals Reports 23% Revenue Growth Year-to-Date - TradingView
Cumberland Pharmaceuticals Leads The Charge With 2 Other Prominent Penny Stocks - Yahoo Finance
Finanzdaten der Cumberland Pharmaceuticals Inc-Aktie (CPIX)
Umsatz
Nettogewinn
Free Cashflow
ENV
4.37%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):